Considering the accumulating evidence that ZNF217 plays an essential role in tumor progression, metastasis, and chemoresistance [68,69], it is predictable that ZNF217-regulated m6A modification, possibly by interaction with METTL3, is relevant in human cancers. The gene discussed is METTL3; the disease is cancer.